WMSA
SAGE

Weiss Multi-Strategy Advisers’s Sage Therapeutics SAGE Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,000
Closed -$301K – 488
2016
Q2 		$301K Buy
+10,000
New +$333K 0.02% 353

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Weiss Multi-Strategy Advisers's SAGE Position: Q4 2021 in Review

Weiss Multi-Strategy Advisers sold out of Sage Therapeutics (SAGE) in Q4 2021, closing a stake of 6,602 shares — an estimated $293K sold.

Weiss Multi-Strategy Advisers first reported a position in SAGE in Q1 2015 and held it in 7 quarters. The position peaked at $753K in Q1 2015. 217 funds tracked by Wall St. Rank hold SAGE as of Q4 2021.

  • Weiss Multi-Strategy Advisers reported no remaining Sage Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 6,602 Sage Therapeutics shares in Q4 2021, an estimated $293K.
  • Weiss Multi-Strategy Advisers first reported a position in Sage Therapeutics in Q1 2015 and held it in 7 quarters.
  • Weiss Multi-Strategy Advisers's Sage Therapeutics position peaked at $753K in Q1 2015.
  • 217 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.